Adverse Drug Reaction Reporting: Awareness Gaps and Educational Interventions among Healthcare Professionals

Adverse drug responses (ADRs) are a significant source of preventable patient harm, and spontaneous reporting by healthcare practitioners (HCPs) remains the principal means by which new safety information on marketed medicines is generated. Under-reporting nevertheless persists across countries and professions, weakening signal detection and delaying regulatory action. This narrative review synthesizes the literature on familiarity of ADR reporting among physicians, nurses, pharmacists and trainees, and on educational strategies to enhance it. Evidence was identified from biomedical databases and authoritative regulatory and international sources, and organized thematically into the definition and classification of ADRs, the framework of drug safety surveillance, the importance of reporting, familiarity and understanding, attitude and practice (KAP) studies, specific understanding and procedural gaps, and organizational and system barriers. Available evidence shows a consistent pattern of favourable attitudes alongside limited understanding of what, how and where to report, with correspondingly low reporting practice, particularly among nurses, pharmacists and young clinicians in India and other developing settings. Barriers include insufficient time, diffidence about causality, misconceptions that only serious or unfamiliar reactions need reporting, cumbersome forms, absence of feedback and limited institutional support. Educational interventions, comprising workshops, lectures, outreach and curriculum-based training, are widely reported to enhance KAP scores and, in several studies, reporting rates, although durability of effect and quality of evidence vary. Embedding drug safety surveillance education in curricula and continuing professional development, together with simplified reporting tools and supportive institutional systems, is key to improving ADR reporting. Finally, practical recommendations for curriculum design, health policy and future research are also outlined.

Authors

Publication Details

Journal
International Journal of Pharmaceutical Research and Applications
Published
2026-11-13
DOI
https://doi.org/10.5281/zenodo.24189774
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adverse Drug Reaction Reporting: Awareness Gaps and Educational Interventions among Healthcare Professionals

J. kumbhar Prof. Sachin., R.Ghongade Rahul, Bais Sanjay K
1 links
International Journal of Pharmaceutical Research and Applications
Pharmacovigilance and Adverse Drug Reactions
article

Adverse Drug Reaction Reporting: Awareness Gaps and Educational Interventions among Healthcare Professionals

J. kumbhar Prof. Sachin., R.Ghongade Rahul, Bais Sanjay K
article en

Abstract

Adverse drug responses (ADRs) are a significant source of preventable patient harm, and spontaneous reporting by healthcare practitioners (HCPs) remains the principal means by which new safety information on marketed medicines is generated. Under-reporting nevertheless persists across countries and professions, weakening signal detection and delaying regulatory action. This narrative review synthesizes the literature on familiarity of ADR reporting among physicians, nurses, pharmacists and trainees, and on educational strategies to enhance it. Evidence was identified from biomedical databases and authoritative regulatory and international sources, and organized thematically into the definition and classification of ADRs, the framework of drug safety surveillance, the importance of reporting, familiarity and understanding, attitude and practice (KAP) studies, specific understanding and procedural gaps, and organizational and system barriers. Available evidence shows a consistent pattern of favourable attitudes alongside limited understanding of what, how and where to report, with correspondingly low reporting practice, particularly among nurses, pharmacists and young clinicians in India and other developing settings. Barriers include insufficient time, diffidence about causality, misconceptions that only serious or unfamiliar reactions need reporting, cumbersome forms, absence of feedback and limited institutional support. Educational interventions, comprising workshops, lectures, outreach and curriculum-based training, are widely reported to enhance KAP scores and, in several studies, reporting rates, although durability of effect and quality of evidence vary. Embedding drug safety surveillance education in curricula and continuing professional development, together with simplified reporting tools and supportive institutional systems, is key to improving ADR reporting. Finally, practical recommendations for curriculum design, health policy and future research are also outlined.

International Journal of Pharmaceutical Research and Applications
Good health and well-being
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon